Literature DB >> 1211496

In vitro measurement of margin of safety of neuromuscular transmission.

D R Waud, B E Waud.   

Abstract

The margin of safety of neuromuscular transmission was measured in isolated guinea pig lumbrical muscles. Twitch height of an indirectly stimulated muscle was reduced stepwise by suitable concentrations of tubocurarine for comparison with the associated occlusion of receptors by the drug. Receptor occlusion was estimated from the effect of tubocurarine on carbachol depolarization measured extracellularly by the moving-fluid electrode technique. Roughly 75-80% of the receptor pool had to be blocked before the twitch height began to fall, and 90-95% had to be blocked before the twitch response was completely abolished. These results agree well with those found previously in vivo. Thus, the present results add further support to the earlier measurements. In particular, artifacts that might have been present because of the complex pharmacokinetic situation in vivo have been ruled out.

Entities:  

Mesh:

Substances:

Year:  1975        PMID: 1211496     DOI: 10.1152/ajplegacy.1975.229.6.1632

Source DB:  PubMed          Journal:  Am J Physiol        ISSN: 0002-9513


  7 in total

1.  Fading responses in the evoked EMG after rocuronium in cats.

Authors:  H Shiraishi; H Suzuki; T Suzuki; N Katsumata; S Ogawa
Journal:  Can J Anaesth       Date:  1992-12       Impact factor: 5.063

2.  Pharmacological aspects of neuromuscular transmission in the isolated diaphragm of the dystrophic (Rej 129) mouse.

Authors:  J B Harris; R R Ribchester
Journal:  Br J Pharmacol       Date:  1979-03       Impact factor: 8.739

3.  Analytical model of some pharmacokinetic and pharmacodynamic properties of fazadinium in man.

Authors:  A A d'Hollander; C Delcroix; P Duvaldestin; D Henzel; E Coussaert; J M Desmonts
Journal:  Eur J Clin Pharmacol       Date:  1983       Impact factor: 2.953

4.  An analytical pharmacodynamic model for nondepolarizing neuromuscular blocking agents.

Authors:  A d'Hollander; C Delcroix
Journal:  J Pharmacokinet Biopharm       Date:  1981-02

5.  Altered active zones, vesicle pools, nerve terminal conductivity, and morphology during experimental MuSK myasthenia gravis.

Authors:  Vishwendra Patel; Anne Oh; Antanina Voit; Lester G Sultatos; Gopal J Babu; Brenda A Wilson; Mengfei Ho; Joseph J McArdle
Journal:  PLoS One       Date:  2014-12-01       Impact factor: 3.240

Review 6.  Factors that affect the onset of action of non-depolarizing neuromuscular blocking agents.

Authors:  Yong Beom Kim; Tae-Yun Sung; Hong Seuk Yang
Journal:  Korean J Anesthesiol       Date:  2017-09-28

7.  Electrophysiological study in neuromuscular junction disorders.

Authors:  Ajith Cherian; Neeraj N Baheti; Thomas Iype
Journal:  Ann Indian Acad Neurol       Date:  2013-01       Impact factor: 1.383

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.